4-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine, 98%, 500mg

GC capillary column ROTI®Cap-1, 50 m, 0.20 mm, 0.35 µm, 1 Piece(s)

2-Amino-5-diethylcarbamoyl-4-methyl-thiophene-3-carboxylic acid methyl ester, 1g

2-Butanol, min. 98.5%, for synthesis, 2.5 l, plastic packaging.

ETHYL 7-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE, 97.0%, 5g

5-tert-Butyl 2-ethyl 6,7-dihydrofuro[3,2-c]pyridine-2,5(4H)-dicarboxylate, 95.0%, 500mg

Ethyl 5-bromo-1H-imidazole-2-carboxylate, 95.0%, 5g

7-Bromo-1,6-dimethyl-indazole, 98%, 500mg

vBRIDP(regR)>98.0%(HPLC)1g

4-Bromoquinolin-3-ol, 95.0%, 250mg

5-METHOXY-1H-INDAZOLE-3-CARBOXYLIC ACID, 95%, 100mg

(R)-2-(PIPERIDIN-3-YL)ACETIC ACID HCL, 97.0%, 250mg

Isochroman-4-amine, 95.0%, 1g